Trial | NCT00036244  Report issue

Title

Synthetic Human Secretin in Children With Autism
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Assess the Efficacy, Safety and Tolerability of RG1068 (Synthetic Human Secretin) in Children With Autism

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    secretin human ...

  • Study Participants

    None
The purpose of the study is to determine whether multiple doses of secretin are safe and effective in the treatment of children with autism.
Study Started
Apr 30
2002
Study Completion
Jan 31
2004
Last Update
Aug 05
2005
Estimate

Drug RG1068 (Synthetic Human Secretin)

Criteria 

Autism
No Results Posted